Aptorum Group delays third-quarter filing over merger accounting
NIKI•Aptorum Group, now Niki BioSolutions, delayed its Form 10-Q for the quarter ended September 30, 2026, because acquisition accounting following its July 20 business combination with DiamiR Biosciences was unfinished. The filing is expected within five calendar days of the prescribed deadline.
1. Filing delay
Aptorum Group, now Niki BioSolutions, delayed its Form 10-Q for the quarter ended September 30, 2026, because accounting for its July 20, 2026, business combination with DiamiR Biosciences was unfinished. The filing is expected within five calendar days of the prescribed deadline.
2. Expected results changes
The company expects significant changes in operating results from the combined operations and nonrecurring transaction costs compared with the corresponding three- and nine-month periods in 2025.




